ESC 365 - Edoxaban in patients with AF following TAVI: ENVISAGE-TAVI AF trial results.

Open Access

Edoxaban in patients with AF following TAVI: ENVISAGE-TAVI AF trial results.

Session: Anticoagulation in Transcatheter Aortic Valve Implantation in Patients with Atrial Fibrillation: Results from ENVISAGE-TAVI AF trial.

Topic: Atrial Fibrillation (AF)

Speaker: Professor N. van Mieghem (Rotterdam, NL)

Sponsored by Daiichi Sankyo Europe GmbH

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Professor Nicolas van Mieghem

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

19 presentations

2 followers

3 more presentations in this session

Welcome and introduction.

Speaker: Doctor S. Saito (Kamakura, JP)

New developments in NOACs and TAVI: How do we apply them in clinical practice?

Speaker: Professor D. Capodanno (Catania, IT)

Panel discussion.

Access the full session

Anticoagulation in Transcatheter Aortic Valve Implantation in Patients with Atrial Fibrillation: Results from ENVISAGE-TAVI AF trial.

Speakers: Professor N. van Mieghem, Doctor S. Saito, Professor D. Capodanno

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by